Mark Garfield
Oxford Asset Management Llp
Assets Managed
$232.202M
Holdings
442
Last Quarter
2026 - Q1
Filed Date
1mo 1d ago
Growth Rate
-5.51%(2Q avg: -7.71%)
Sustained Growth
0 quarters
Portfolio positions
This chart displays the top 10 holdings in Oxford Asset Management Llp's 2026 - Q1 portfolio, based on their 13F SEC filing, out of a total of 442 positions.
Assets under management
The assets under management (AUM) of Oxford Asset Management Llp over the past 10 years (40 quarters) show continuous growth in total asset value over the last 0 quarters. As of the latest 13F SEC filing for 2026 - Q1, they manage 232.202M in assets, with a quarterly growth rate of -5.51% and a 2-quarter average growth rate of -7.71%. The portfolio is managed by Mark Garfield, and others.
Portfolio holdings
| Investment | Portfolio % | Reported Value | Recent Activity |
|---|---|---|---|
XBI Spdr S&p Biotech Etf
| 5.36% | $12.424M 97,266 shares@ $127.73 avg price | Increased 79.11% |
WIX Wix.com Ltd
| 2.2% | $5.093M 56,542 shares@ $90.08 avg price | New Position |
BSX Boston Scientific Corp
| 1.61% | $3.72M 59,288 shares@ $62.75 avg price | Increased 1112.69% |
SYY Sysco Corp
| 1.26% | $2.903M 40,695 shares@ $71.33 avg price | Increased 575.1% |
MU Micron Technology Inc
| 1.24% | $2.864M 8,477 shares@ $337.85 avg price | Decreased -12.21% |
VNOM Viper Energy Inc-cl A
| 1.05% | $2.416M 51,405 shares@ $47.0 avg price | New Position |
META Meta Platforms Inc-class A
| 1.04% | $2.394M 4,185 shares@ $572.13 avg price | Increased 200.65% |
EQT Eqt Corp
| 0.98% | $2.263M 35,552 shares@ $63.64 avg price | New Position |
CVX Chevron Corp
| 0.93% | $2.14M 10,342 shares@ $206.91 avg price | New Position |
DAWN Day One Biopharmaceuticals I
| 0.93% | $2.139M 99,747 shares@ $21.45 avg price | New Position |
1-10 of 442